James P. Snyder
Corporate Officer/Principal bij Emory University
Profiel
James P.
Snyder is the founder of Altiris Therapeutics, Inc. (founded in 2005) where he held the title of Member-Scientific Advisors in 2012.
He is currently working at Emory University as the Director-Biostructural Research since 2013.
Previously, he worked at Metastatix, Inc. from 2005 to 2009 as the Head-Rational Drug Design.
Dr. Snyder obtained a doctorate degree from Cornell University and an undergraduate degree from Saint Martin's College.
Actieve functies van James P. Snyder
| Bedrijven | Functie | Begin |
|---|---|---|
| Emory University | Corporate Officer/Principal | - |
Eerdere bekende functies van James P. Snyder
| Bedrijven | Functie | Einde |
|---|---|---|
Metastatix, Inc.
 Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Corporate Officer/Principal | 22-06-2009 |
Altiris Therapeutics, Inc.
 Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Oprichter | - |
Opleiding van James P. Snyder
| Cornell University | Doctorate Degree |
| Saint Martin's College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Metastatix, Inc.
Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Health Technology |
Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Health Technology |
